Home / GLIS3 Knockout Cell Lines

GLIS3 Knockout Cell Lines

Gene: GLIS3

Official Full Name: GLIS family zinc finger 3provided by HGNC

Gene Summary: This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear protein with five C2H2-type zinc finger domains. This protein functions as both a repressor and activator of transcription and is specifically involved in the development of pancreatic beta cells, the thyroid, eye, liver and kidney. Mutations in this gene have been associated with neonatal diabetes and congenital hypothyroidism (NDH). Alternatively spliced variants that encode different protein isoforms have been described but the full-length nature of only two have been determined. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO06302 GLIS3 Knockout cell line (HeLa) Human GLIS3 1:3~1:6 Negative Online Inquiry
KO06303 GLIS3 Knockout cell line (HCT 116) Human GLIS3 1:2~1:4 Negative Online Inquiry
KO06304 GLIS3 Knockout cell line (HEK293) Human GLIS3 1:3~1:6 Negative Online Inquiry
KO06305 GLIS3 Knockout cell line (A549) Human GLIS3 1:3~1:4 Negative Online Inquiry

Background

GLIS3 Gene Knockout Cell Lines are specialized cellular models engineered to lack the gene encoding the GLIS3 transcription factor, which plays a critical role in various biological pathways, including cell growth, differentiation, and metabolism. By utilizing CRISPR-Cas9 gene-editing technology, these knockout cell lines allow researchers to investigate the functional implications of GLIS3 absence in a controlled environment, facilitating the elucidation of its roles in health and disease.

The key functions of GLIS3 are closely linked to its regulatory capacity on insulin gene transcription and its involvement in the development of pancreatic β-cells. Therefore, GLIS3 Gene Knockout Cell Lines serve as a powerful tool for studying diabetes, obesity, and related metabolic disorders. By assessing cellular responses to stimuli, such as glucose levels or insulin, researchers can elucidate mechanistic insights that may lead to novel therapeutic strategies.

This product is particularly significant not only for basic research but also for translational applications in clinical settings. The characterization of GLIS3's role in diseases like type 1 and type 2 diabetes positions these knockout cell lines as valuable resources for drug discovery and the development of personalized medicine approaches.

One of the major advantages of our GLIS3 Gene Knockout Cell Lines is their robust and validated genetic modification, ensuring reproducibility and reliability in experimental outcomes. Compared to traditional gene knockdown methods, such as siRNA, our cell lines provide stable and permanent gene inactivation, allowing for long-term studies and high-throughput screening applications.

Researchers and clinicians will find great value in these knockout cell lines as they accelerate the journey from hypothesis to experimental data, contributing to the understanding of pathophysiological processes and offering insights into potential interventions. Our company, with its strong background in innovative genetic engineering and dedication to advancing biological research, is committed to providing top-tier products like GLIS3 Gene Knockout Cell Lines that empower scientists in their quest for knowledge and therapeutic advancement.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.